+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rosai-Dorfman Disease - Global Strategic Business Report

  • PDF Icon

    Report

  • 372 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6106242
The global market for Rosai-Dorfman Disease was valued at US$627.8 Million in 2025 and is projected to reach US$934.2 Million by 2032, growing at a CAGR of 5.8% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Rosai-Dorfman Disease Market - Key Trends & Drivers Summarized

Decoding a Rare Disease: How Better Diagnostics and Targeted Therapies Are Reshaping Rosai-Dorfman Treatment Landscape

What Is Rosai-Dorfman Disease and Why Is It Challenging to Diagnose and Treat?

Rosai-Dorfman Disease (RDD), or sinus histiocytosis with massive lymphadenopathy, is a rare non-Langerhans cell histiocytosis characterized by overproduction and accumulation of histiocytes in lymph nodes and extranodal tissues. It often presents with painless cervical lymphadenopathy but may involve the skin, respiratory tract, central nervous system, and other organs, leading to significant diagnostic ambiguity. The disease can mimic malignancies such as lymphoma or systemic autoimmune disorders, making early and accurate diagnosis difficult.

RDD’s pathogenesis remains poorly understood, though it is suspected to involve immune dysregulation or infectious triggers. The heterogeneity in presentation-ranging from indolent lymph node enlargement to aggressive, multi-organ involvement-complicates treatment strategies. Traditionally, the disease has been managed conservatively due to its potential for spontaneous remission. However, in cases of vital organ involvement or disfiguring progression, corticosteroids, immunosuppressants, or surgical intervention may be warranted. Emerging evidence has shown the utility of targeted therapies, including MEK inhibitors, in patients with molecular mutations such as KRAS or NRAS, pointing toward a more personalized treatment future.

How Is Diagnostic Innovation Transforming the Clinical Landscape for RDD?

Histopathological analysis remains the gold standard for diagnosing Rosai-Dorfman Disease, with hallmark features such as emperipolesis and S100+ histiocytes. However, recent advances in molecular diagnostics and imaging modalities are improving early detection, subclassification, and monitoring. Whole exome sequencing (WES) and next-generation sequencing (NGS) have uncovered recurrent mutations in the MAPK/ERK pathway in a subset of RDD patients, allowing stratification based on molecular etiology and potential therapy responsiveness.

Imaging plays a pivotal role in evaluating disease extent and therapeutic response. Positron emission tomography-computed tomography (PET-CT) is increasingly used to identify active lesions, guide biopsies, and monitor residual disease. MRI is preferred in cases of central nervous system involvement, where differentiation from other histiocytic or granulomatous diseases is critical. Additionally, circulating biomarkers and cytokine profiling are under investigation for tracking disease activity and treatment efficacy-tools that could help move toward less invasive longitudinal care models.

These diagnostic advancements are reshaping clinical management by supporting earlier intervention, avoiding unnecessary surgical excisions, and guiding treatment escalation based on molecular risk profiles. Diagnostic standardization is particularly important given the disease’s rarity and geographical variability in clinician familiarity and diagnostic access.

Which Patient Groups and Healthcare Markets Are Most Affected by RDD?

RDD has a global distribution but is more commonly diagnosed in children, adolescents, and young adults, with a slight male predominance. It remains largely underreported, especially in low-resource settings where access to advanced imaging and histological expertise is limited. While many cases are limited to lymph nodes and resolve without intervention, a significant proportion-up to 40%-show extranodal involvement requiring aggressive management.

The market for RDD diagnostics and therapeutics is more pronounced in tertiary care centers, academic hospitals, and specialty hematology-oncology clinics in North America, Europe, and East Asia. The U.S. and Japan have shown strong clinical research interest, with academic registries and multi-institutional cohorts helping to define the disease’s clinical spectrum and treatment outcomes. Pharmaceutical companies focusing on rare diseases are also expanding their pipelines to include investigational drugs that could potentially be repurposed for RDD treatment, particularly in mutation-positive cases.

Patient advocacy groups, rare disease foundations, and government-sponsored research initiatives are playing a crucial role in improving disease awareness, diagnostic equity, and access to experimental therapies. This is particularly important for underserved communities and global regions where delayed diagnosis often results in poorer outcomes.

What Is Driving the Momentum in the Rosai-Dorfman Disease Market?

The growth in the Rosai-Dorfman Disease market is driven by several factors, notably advances in molecular diagnostics, increased physician awareness, and a shift toward targeted and individualized treatment protocols. The discovery of actionable mutations in a subset of RDD patients has opened the door for clinical trials involving MEK inhibitors, immune checkpoint blockers, and biologics that modulate macrophage activation. This aligns the RDD market with broader trends in rare disease therapeutics where precision medicine is replacing empiric treatment.

Increased publication activity, establishment of global RDD registries, and the adoption of multidisciplinary tumor boards for histiocytic disorders are improving diagnostic rates and care pathways. Health systems in developed economies are allocating more resources for orphan diseases, aided by favorable regulatory frameworks that incentivize orphan drug development. The inclusion of RDD in histiocytosis classification systems and diagnostic algorithms is also encouraging earlier screening and recognition among general practitioners and specialists alike.

Lastly, the convergence of digital pathology, AI-enabled biopsy interpretation, and collaborative research networks is set to reduce diagnostic variability and accelerate therapeutic innovation. As RDD shifts from an enigmatic and rare disorder to a genomically characterized and clinically stratified disease, the market will see expanded opportunities for pharmaceutical development, clinical trials, and precision diagnostics across key healthcare systems worldwide.

Report Scope

The report analyzes the Rosai-Dorfman Disease market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Type (Classic Rosai-Dorfman Disease, Extranodal Rosai-Dorfman Disease); Administration Route (Oral Administration, Parenteral Administration, Other Administration Routes); End-Use (Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Classic Rosai-Dorfman Disease segment, which is expected to reach US$520.8 Million by 2032 with a CAGR of a 4.7%. The Extranodal Rosai-Dorfman Disease segment is also set to grow at 7.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $171.0 Million in 2025, and China, forecasted to grow at an impressive 8.7% CAGR to reach $189.6 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Rosai-Dorfman Disease Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Rosai-Dorfman Disease Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Rosai-Dorfman Disease Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Amgen, Amicus Therapeutics, AstraZeneca, Bayer, BMS (Bristol-Myers Squibb) and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Rosai-Dorfman Disease market report include:

  • Amgen
  • Amicus Therapeutics
  • AstraZeneca
  • Bayer
  • BMS (Bristol-Myers Squibb)
  • GSK (GlaxoSmithKline)
  • Janssen (Johnson & Johnson)
  • Kura Oncology
  • Merck & Co.
  • Novartis
  • Pfizer
  • Protalix BioTherapeutics
  • Regeneron Pharmaceuticals
  • Roche
  • Sanofi
  • Takeda
  • Ultragenyx Pharmaceutical
  • Vertex Pharmaceuticals
  • Blueprint Medicines
  • Incyte

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Rose Extract - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Natural and Botanical Ingredients Propels Growth in Rose Extract Applications
  • Expansion of Organic Skincare and Cosmetics Drives Inclusion of Rose-Based Actives
  • Growing Use in Aromatherapy and Wellness Products Strengthens Business Case for Therapeutic Applications
  • Consumer Preference for Plant-Derived Anti-Aging Agents Spurs Innovation in Rose-Infused Serums
  • Increased Adoption in Nutraceuticals and Herbal Supplements Expands Functional Ingredient Demand
  • Wider Availability of Solvent-Free Extraction Techniques Enhances Product Purity and Yield
  • Premiumization in Personal Care Formulations Drives Market for High-Grade Floral Extracts
  • Demand for Transparent and Ethical Sourcing Practices Strengthens Appeal Among Eco-Conscious Consumers
  • Proliferation of Clean Beauty Brands Accelerates Rose Extract Inclusion in Ingredient Lists
  • Rise in Luxury and Niche Fragrance Products Fuels Demand for High-Quality Rosa Damascena Derivatives
  • Growth in Ayurvedic and Holistic Health Segments Expands Traditional Use-Case Scenarios
  • Increased Labeling of Rose Extract as a Multifunctional Ingredient Drives Market Differentiation
  • Expansion of Natural Preservative Systems Supports Use of Rose Extract in Product Stabilization
  • Digital Marketing by D2C Skincare Brands Amplifies Consumer Awareness of Botanical Benefits
  • Growing Interest in Floral-Based Functional Beverages Promotes Crossover Into Food Applications
  • Advancements in Cold-Press and CO? Extraction Enhance Bioactive Retention and Efficacy
  • Rising Spa and Salon Demand for Botanical Facials Spurs Institutional Procurement
  • Sustainability Certifications and Fair Trade Labeling Bolster Brand Trust and Consumer Preference
  • Improved Global Logistics and Cold Chain Storage Enhance Access to Region-Specific Varietals
  • Emergence of Concentrated and Standardized Extracts Drives Adoption in R&D-Intensive Formulations
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Rose Extract Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Rose Extract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Rose Extract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Rose Extract by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Rose Oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Rose Oil by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Rose Oil by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Rose Hip Fruit Extract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Rose Hip Fruit Extract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Rose Hip Fruit Extract by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Rose Water by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Rose Water by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Rose Water by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Fragrance & Cosmetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Fragrance & Cosmetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Fragrance & Cosmetics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Food & Beverages Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Food & Beverages Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Food & Beverages Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 24: USA Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: USA 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 26: USA Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 27: USA Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: USA 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 30: Canada Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: Canada 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 32: Canada Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 33: Canada Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: Canada 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
JAPAN
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 36: Japan Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 37: Japan 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 38: Japan Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 39: Japan Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 40: Japan 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
CHINA
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 42: China Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 43: China 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 44: China Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 45: China Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 46: China 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
EUROPE
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Rose Extract by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 48: Europe Historic Review for Rose Extract by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 49: Europe 13-Year Perspective for Rose Extract by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 50: Europe Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 51: Europe Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 52: Europe 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 53: Europe Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 54: Europe Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 55: Europe 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
FRANCE
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 57: France Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 58: France 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 59: France Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 60: France Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 61: France 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
GERMANY
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 63: Germany Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 64: Germany 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 65: Germany Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 66: Germany Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 67: Germany 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 69: Italy Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 70: Italy 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 71: Italy Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 72: Italy Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 73: Italy 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 75: UK Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 76: UK 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 77: UK Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 78: UK Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 79: UK 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 81: Spain Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 82: Spain 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 83: Spain Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 84: Spain Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 85: Spain 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 87: Russia Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 88: Russia 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 89: Russia Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 90: Russia Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 91: Russia 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 93: Rest of Europe Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 94: Rest of Europe 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 96: Rest of Europe Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 97: Rest of Europe 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
ASIA-PACIFIC
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Rose Extract by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Rose Extract by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 100: Asia-Pacific 13-Year Perspective for Rose Extract by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Rose Extract by Product - Rose Oil, Rose Hip Fruit Extract and Rose Water Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 103: Asia-Pacific 13-Year Perspective for Rose Extract by Product - Percentage Breakdown of Value Sales for Rose Oil, Rose Hip Fruit Extract and Rose Water for the Years 2020, 2026 & 2032
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Rose Extract by Application - Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 106: Asia-Pacific 13-Year Perspective for Rose Extract by Application - Percentage Breakdown of Value Sales for Fragrance & Cosmetics Application, Pharmaceuticals Application and Food & Beverages Application for the Years 2020, 2026 & 2032
AUSTRALIA
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Rose Extract Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amgen
  • Amicus Therapeutics
  • AstraZeneca
  • Bayer
  • BMS (Bristol-Myers Squibb)
  • GSK (GlaxoSmithKline)
  • Janssen (Johnson & Johnson)
  • Kura Oncology
  • Merck & Co.
  • Novartis
  • Pfizer
  • Protalix BioTherapeutics
  • Regeneron Pharmaceuticals
  • Roche
  • Sanofi
  • Takeda
  • Ultragenyx Pharmaceutical
  • Vertex Pharmaceuticals
  • Blueprint Medicines
  • Incyte

Table Information